Country for PR: United States
Contributor: PR Newswire New York
Wednesday, June 29 2022 - 09:51
Tarkus, the Colombian phyto-therapeutic laboratory that is conquering the world with its medical cannabis products
BOGOTA, Colombia, June 29, 2022 /PRNewswire-AsiaNet/ --

-- Tarkus Pharma Lab, the first pharmaceutical laboratory located in a Free 
Trade Zone in Colombia, has become a global industry benchmark, developing raw 
materials and final products derived from medical cannabis with the highest 
quality, and exporting to various regions of the world.

-- The National Institute for Drug and Food Surveillance (Instituto Nacional de 
Vigilancia de Medicamentos y Alimentos) INVIMA in Colombia has certified this 
laboratory in Good Manufacturing Practices (GMP) to produce phyto-therapeutic 
products for free use.

Tarkus Pharma Lab, the first pharmaceutical laboratory of medicinal Cannabis 
located in Colombia's free trade zone in Bogota, was certified by INVIMA (the 
entity responsible for controlling and verifying that products comply with 
sanitary requirements for importation and distribution), with the endorsement 
of Good Manufacturing Practices (GMP), allowing the manufacture of 
phyto-therapeutic products derived from Cannabis for free use and with export 

Currently, the company has cannabis-derived raw materials, standardized 
mixtures and magister formulas. By obtaining the certification, the laboratory 
is authorized to produce finished phyto-therapeutic products (ingestible 
products for medicinal purposes from natural origin).

"To achieve this important step, we have the required investment and a team of 
experts in the pharmaceutical industry. Additionally, we will place our 
products in pharmacies and department stores, facilitating access to thousands 
of people with chronic pathologies, so that they can enjoy the benefits offered 
by cannabis-based products," said Alejandro Venegas, CEO of Tarkus Pharma Lab.

Although the export of raw material does not require INVIMA certification, it 
is a requirement for the commercialization of the final labeled product that 
reaches consumers. For Tarkus, having the support of regulatory entities is a 
commitment to its customers, represented in quality assurance of raw materials 
and final products, as well as a seal of confidence for users.

Tarkus is looking for a local partner to enter the Australian market with high 
quality products with best in market prices.

According to Procolombia, government entity that promotes exports from this 
Latin American country, Australia is the second country with the largest 
medical cannabis market outside of North America, with more than 100,000 

For further information

SOURCE: Tarkus Pharma Lab

CONTACT: Isabel Matta,; Tatiana Casas,